Saurabh Zanwar, Myeloma, Amyloid and Dysproteinemia Fellow at Mayo Clinic, shared a post on X:
“Excited to be at ASH24!
We will be presenting some really exciting data on flow-based S-phase plasma cells as a simple and powerful marker for functionally high-risk disease, and report novel information from sequencing a large cohort of patients with extramedullary disease!”
